Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer. - Wikidata - wikimedia - TriplyDB

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

http://www.wikidata.org/entity/Q38222834

about

Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.DNA Repair Pathway Alterations in Bladder Cancer.Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis Modelling bladder cancer in mice: opportunities and challenges.N‑Myc downstream‑regulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis.Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer.ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting.Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use FOXA1, GATA3 and PPARɣ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.New discoveries in the molecular landscape of bladder cancer.Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence.Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.The role of genomics in the management of advanced bladder cancer.The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.RhoGDIβ Promotes Sp1/MMP-2 Expression and Bladder Cancer Invasion Through Perturbing miR-200c-Targeted JNK2 Protein Translation.Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer.Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.Biomarkers for precision medicine in bladder cancer.In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.Contemporary update on neoadjuvant therapy for bladder cancer.Carcinoma of the Urethra.Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis Claudin-low bladder tumors are immune infiltrated and actively immune suppressed Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes

P2860

Q26771263-4CF4ABF2-13E7-49D3-9C27-218317B461F8 Q27310019-746FFFE8-2493-45BB-A8B7-13F4FDF09DC8 Q33593041-92464E10-D49A-48FB-9214-938ADDF63CBF Q33607945-9027CC93-C19A-4890-8C95-E92D1A044D43 Q33817493-99492EDF-3CFC-49F1-A629-6DE536036AE9 Q35285703-52691ADB-62D0-415A-9325-9F4339E1790A Q35736249-785B3BAB-54E5-4EA5-A004-6D74664C7B83 Q35767570-B0F7166F-C312-4FC0-A9E5-5EB39EF8C215 Q36342882-28FA5B72-9435-444D-8D6A-7CB3E2F9FA1B Q36611884-D00A8BD0-75DF-4D21-B934-3C4002A6E393 Q36867680-54C7F9AD-B65A-49F3-A32E-CF445F26A41A Q37040720-1D84AE13-1FA3-47A6-9FED-ACB07E2A4AE3 Q37053995-CD26FBA6-FC4E-424E-B695-9E8026A2AE63 Q37363521-489B87B5-8539-4201-9560-3498975F8BD5 Q37479778-EB07F4E7-1D42-4576-8F4E-196021AE9C31 Q37578747-0FB5A6E7-8E0D-4087-8314-188AC0E4D1BE Q37593293-1D1D4747-0813-4F63-91D1-257C6CC75564 Q37616743-CFC37358-7CA6-4F74-AB97-03A7329C4FCE Q37696983-67FC2B65-5952-4899-8FE0-ED933E06C928 Q37723023-01ACDFA4-F0C1-44D9-B3C0-3E0B4FED6860 Q37737877-E73D711F-513B-4828-A8F2-0305D495278E Q38261693-059E7102-3D23-4959-B413-6B2D48A2250D Q38297729-498C177E-D6C6-4BA6-BBAA-412D2AF6CC68 Q38342992-A0177692-69A6-4F61-B49A-3387FEDEE022 Q38419495-EF546B5F-12F9-4BF3-9DBE-7A5DA6908ACB Q38605628-EC95A517-6258-4716-B032-5FC8B957CF7E Q38627721-0D39DF74-991E-4B79-AAB6-C1F7C8C8FC0A Q38769921-50E1EE13-58E1-4F2B-8886-9F4E5360E178 Q38862963-BFB108CA-B612-4126-B993-A4FF0B67F3C0 Q38891922-A6D19485-13E5-4318-9DC8-89033A71A510 Q38893600-D45782C2-6F41-4CBC-AB51-4C529060290F Q38946859-B1A611CF-5B14-43C9-9CD9-A099D6166A77 Q39023158-D466176C-AB98-4404-8D61-9BD285CDE2B1 Q39028041-91B670D6-CA89-4C6E-948E-6BF212641647 Q39177293-F2D2A35A-9745-4E1B-9074-389FE04B26BF Q40085327-CE0CB0B0-986F-428E-9A37-BB086360A3D4 Q41133948-376213DA-E23D-4C9A-8701-16AD16C2CCA7 Q41160701-80F4F11E-C48C-4279-9C66-69E59DA25F0F Q41273487-931DE57F-9532-4F54-B304-50F38F05BDD0 Q41471202-22E555D6-7E74-4D1B-B201-43B88B838B43

P2860

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

http://www.wikidata.org/entity/Q38222834

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

@en

type

label

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

@en

prefLabel

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

@en

P1433

Q38222834-9F81AC59-8E16-4DC5-9C58-94DAC912D6D1

P1476

Q38222834-D4408C16-B30B-4D63-8145-F2FA3DA81358

P2093

Q38222834-09BA71A4-4503-4FF7-BB9E-C3E2A5AA89CA

Q38222834-98596561-95BF-486E-A3FE-8DDF98C82C81

Q38222834-AF1C9ADD-4A36-4CD8-8E2A-8C841B68185A

Q38222834-BDAADD6C-25FD-46D1-9AFF-EFE88CE41EC9

Q38222834-C3AD61BB-8B92-4A65-BAC6-E9957921B2F7

Q38222834-DFB6A652-981A-4359-99EC-DBBEA5A90D85

P2860

Q38222834-0480D45F-2D12-4E13-9829-33A4AE31CA60

Q38222834-04BCD764-16FB-4379-99FA-BA3FA0E7BBBC

Q38222834-06C5B286-6E33-4C96-B764-6DB65B90B960

Q38222834-0969C7BE-C889-44EA-B19D-AFB5BB8FF5B4

Q38222834-0D065E97-D3A5-4202-B591-6425C001307E

Q38222834-165C0AA5-24F1-40E4-AF5B-3A4FFC57623A

Q38222834-17E21594-8F58-406C-8E51-200178B21D44

Q38222834-1A13A89A-5854-4DF1-8E5B-7B5F3DF0E569

Q38222834-1A6FA1A5-51BF-46A3-816D-F4EF7D92A1C3

Q38222834-1D5B3C15-F5CD-4FAE-BD6B-FECD9F46FF27

P2888

Q38222834-5162A0D8-608E-4D3F-A50B-EB309E504EC4

P304

Q38222834-13ED9DB8-D783-4F82-8642-9AB59A86D6B1

P31

Q38222834-7EBB9E96-E0A6-41C7-A194-196B0B486E8B

P356

Q38222834-613814B2-6CD8-4E96-B272-878E9AF9E6FE

P407

Q38222834-39995F2E-681A-475B-B40D-B33967027FCC

P433

Q38222834-FD1B4C97-9618-4BDC-9978-DCC9F76BEF5D

P478

Q38222834-72DB62F9-D4BE-496F-870F-FCCBAF454E23

P50

Q38222834-F0EF454D-F539-40C7-9F57-A05D91BE14C1

P577

Q38222834-6A5A4B16-A24C-4E76-8C1F-0EC64938B2CF

P6179

Q38222834-41D6BD68-26CD-4C88-8547-7298841E7DA4

P698

Q38222834-2B8409BA-1541-404F-A487-1E66BD9332DE

P356

NRUROL.2014.129

P1433

Nature Reviews Urology

P1476

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

@en

P2093

Arlene Siefker-Radtke

http://www.w3.org/2001/XMLSchema#string

Bogdan Czerniak

http://www.w3.org/2001/XMLSchema#string

Colin Dinney

http://www.w3.org/2001/XMLSchema#string

David J McConkey

http://www.w3.org/2001/XMLSchema#string

Woonyoung Choi

http://www.w3.org/2001/XMLSchema#string

Xiaoping Su

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

Genome sequencing identifies a basis for everolimus sensitivity

Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Normal and neoplastic urothelial stem cells: getting to the root of the problem

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.

P2888

nrurol.2014.129

P304

400-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRUROL.2014.129

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001363417

http://www.w3.org/2001/XMLSchema#string

P698

24960601

http://www.w3.org/2001/XMLSchema#string